Javier Bibb, MD
Nephrology · Washington Terrace, UTNPI 1871513358
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,447 of the $1,662 with a category attached, or 87.1%. It is spread thinly across 20 manufacturers, the largest accounting for just 20.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $694 and has fallen 54.0% since, to $319 in 2024.
Across 65 payments — averaging $25.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$340
- AstraZeneca$222
- Outset Medical Inc$179
- Calliditas Therapeutics US Inc.$116
- OPKO Pharmaceuticals, LLC$107
- Sanofi$104
- plus $595 from 14 others
What the payments were for
- Food & beverage$1,44787%
- Education$21413%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 14 | $340 |
| AstraZeneca(2 entities) | 13 | $222 |
| Outset Medical Inc | 1 | $179 |
| Calliditas Therapeutics US Inc. | 1 | $116 |
| OPKO Pharmaceuticals, LLC | 6 | $107 |
| Sanofi | 1 | $104 |
| Akebia Therapeutics Inc | 3 | $68 |
| Bayer | 4 | $63 |
| Vifor Pharma, Inc. | 3 | $62 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $54 |
| Mallinckrodt Hospital Products Inc. | 2 | $53 |
| Aurinia Pharma U.S., Inc. | 2 | $50 |
| Boston Scientific | 2 | $44 |
| Genentech USA, Inc. | 2 | $40 |
| Amgen | 2 | $35 |
| Daiichi Sankyo Inc. | 2 | $33 |
| Arbor Pharmaceuticals, Inc. | 2 | $27 |
| Veloxis Pharmaceuticals, Inc. | 1 | $23 |
| Mallinckrodt Enterprises LLC | 1 | $21 |
| Alnylam Pharmaceuticals Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,662 in reported general payments places this provider in the 55th percentile of 74 nephrology providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other nephrology in Washington Terrace
- Ron ZuiderwegWashington Terrace$1K
- Sanjiv AnandSouth Salt Lake$144K
- Alfred CheungSalt Lake City$132K
- Donald KohanSalt Lake City$119K
- Anitha VijayanMurray$118K
- Fuad ShihabSalt Lake City$83K
- William BaragerProvo$13K
- Srinivasa BeddhuSalt Lake City$8K
- George JaradSaint George$7K
- Carlos MercadoSt George$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.